Welcome to VIRTTU

VIRTTU Biologics is a clinical stage biotechnology company pioneering the transformative development of viruses for therapeutic purposes to create life-saving treatments for cancer.

The Company’s strength is built on that most valuable of assets – the knowledge that the technology works and is safe in patients. 

By remodeling a common virus we have developed and patented a series of medicines that have the potential to transform treatment and target many forms of cancer effectively.

Our most advanced product, a unique cancer-destroying (oncolytic) virus, has the potential to radically change oncology therapy through its potent ability to seek out and multiply only in cancer cells: destroying them whilst leaving healthy cells unaffected.

We are now actively progressing the clinical development programme required to secure regulatory approval to market our lead product, SEPREHVIR®, for use in cancer therapy.